[HTML][HTML] The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy …

A Marson, G Burnside, R Appleton, D Smith, JP Leach… - The Lancet, 2021 - thelancet.com
Background Valproate is a first-line treatment for patients with newly diagnosed idiopathic
generalised or difficult to classify epilepsy, but not for women of child-bearing potential …

[HTML][HTML] The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label …

A Marson, G Burnside, R Appleton, D Smith, JP Leach… - The Lancet, 2021 - thelancet.com
Background Levetiracetam and zonisamide are licensed as monotherapy for patients with
focal epilepsy, but there is uncertainty as to whether they should be recommended as first …

[HTML][HTML] Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised …

FJK O'Callaghan, SW Edwards, FD Alber… - The Lancet Child & …, 2018 - thelancet.com
Background Infantile spasms constitute a severe form of epileptic encephalopathy. In the
International Collaborative Infantile Spasms Study (ICISS), we showed that combining …

GLRB is the third major gene of effect in hyperekplexia

SK Chung, A Bode, TD Cushion… - Human molecular …, 2013 - academic.oup.com
Glycinergic neurotransmission is a major inhibitory influence in the CNS and its disruption
triggers a paediatric and adult startle disorder, hyperekplexia. The postsynaptic α1-subunit …

Hemimegalencephaly and focal megalencephaly in tuberous sclerosis complex.

PD Griffiths, SA Gardner, M Smith… - American journal of …, 1998 - Am Soc Neuroradiology
We describe two children with complex cortical malformations as well as the typical
intracranial manifestations of tuberous sclerosis complex. One child had …

A second locus for Aicardi-Goutieres syndrome at chromosome 13q14–21

M Ali, LJ Highet, D Lacombe, C Goizet… - Journal of medical …, 2006 - jmg.bmj.com
Background: Aicardi-Goutières syndrome (AGS) is an autosomal recessive, early onset
encephalopathy characterised by calcification of the basal ganglia, chronic cerebrospinal …

[HTML][HTML] Low frequency centromedian thalamic nuclei deep brain stimulation for the treatment of super refractory status epilepticus: a case report and a review of the …

I Stavropoulos, R Selway, H Hasegawa… - … Clinical Research in …, 2021 - brainstimjrnl.com
Super refractory status epilepticus (srSE) refers to a SE that fails to respond to 1st and 2nd
line treatments and persists after 24 hours of anaesthesia carrying increased risk of …

The cortical focus in childhood absence epilepsy; evidence from nonlinear analysis of scalp EEG recordings

PG Sarrigiannis, Y Zhao, F He, SA Billings… - Clinical …, 2018 - Elsevier
Objective To determine the origin and dynamic characteristics of the generalised hyper-
synchronous spike and wave (SW) discharges in childhood absence epilepsy (CAE) …

Severe infantile axonal neuropathy with respiratory failure

JM Wilmshurst, A Bye, C Rittey… - Muscle & Nerve …, 2001 - Wiley Online Library
Abstract We describe 5 infants (4 male, 1 female) with a severe intractable form of motor‐
sensory axonal neuropathy. All became ventilator‐dependent, 4 have since died and 1 …

Aicardi–Goutières syndrome: monogenic recessive disease, genetically heterogeneous disease, or multifactorial disease?

S Fauré, I Bordelais, C Marquette, C Rittey… - Clinical …, 1999 - Wiley Online Library
Aicardi–Goutières syndrome (AGS) is a severe progressive familial encephalopathy, which
is usually diagnosed shortly after birth. Using the principle of homozygosity mapping …